3Suppliers
0Customers
3Debt Items
2Related Chains

Source-Backed Evidence Depth

Relmada Therapeutics, Inc. (RLMD) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

7Total relationships
1Distinct source URLs
6High confidence
0.863Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Relmada Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
ASARINA-PHARMA-AB ASARINA-PHARMA-AB 92% On February 3, 2025, the Company entered into an Asset Purchase Agreement (the Purchase Agreement) with Asarina Pharma AB (Asarina), a Swedish corporation, pursuant to which the Company has agreed, s…
TRIGONE TRIGONE 90% On March 24, 2025, the Company entered into an Exclusive License Agreement with Trigone, a privately held Israeli company. The license agreement is for Trigone’s NDV-01 product
BKTI BK Technologies Corporation 62% Reciprocal relationship from BKTI graph: or otherwise, after the date of this report. Readers are cautioned not to place undue reliance on these forward-looking statements. Executive Summary BK Techn…

Relmada Therapeutics, Inc. Customers

No clients on recordNo downstream customers found in our database for Relmada Therapeutics, Inc..

Relmada Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
RLMD-DEBT Debt stack $110,247 90% Market cache reports total debt of $110,247.
RLMD-DEBT-12218 Warrants outstanding: 1264523 90% xbrl warrant detail from xbrl 2025-11-05.
RLMD-DEBT-12219 Xbrl Convertible 90% xbrl convertible detail from xbrl 2018-10-31.

Relmada Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Relmada Therapeutics, Inc..

Relmada Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
RLMD-OWNER-JANUS-HENDERSON-GROUP-PLC JANUS HENDERSON GROUP PLC 90% 13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 106 tracked holders.

Relmada Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BKTI BK Technologies Corporation 100.00 1 ['supplier']
MSI Motorola Solutions, Inc. 50.00 2
🔐
RLMD
Unlock RLMD Supply Chain Data
Verified relationships include:
ASARINA-PHARMA-ABASARINA-PHARMA-ABSupplier92%
TRIGONETRIGONESupplier90%
+3 more relationships locked
Subscribe — View plans →